Foramen Ovale, Patent
18
1
3
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
NobleStitch EL STITCH Trial is a PFO Comparative Trial
Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study
Investigation of Nickel Sensitization After Percutaneous Implantation of Patent Foramen Ovale Occluder
Long-term Outcomes After Percutaneous Closure of PFO
Decompression Sickness in Divers With or Without Patent Foramen Ovale
Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale
Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation
The Effect on EPCs by Successful Cardiac Occlusion Device Implantation
Stitch Closure of PFO and Septal Repair
Correlation of Right-left Shunt Detection in Cardioembolism Etiology in Stroke Patient.
Patent Foramen Ovale and the Risk of Postoperative Delirium Following Elective Hip and Knee Arthroplasty Surgeries
Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine
Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen Ovale
InterSEPT: In-Tunnel SeptRx European PFO Trial
Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System
The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness